Caspofungin in a pediatric patient with persistent candidemia

Karin K. Wertz, Robert K. Pretzlaff

Research output: Contribution to journalArticlepeer-review

21 Scopus citations


Objective: To describe the response of a child with persistent fungemia to caspofungin, a member of the echinocandin class of antifungals. Design: Descriptive case report. Setting: Pediatric intensive care unit at a university teaching hospital. Patient: A 3-yr-old female with persistent candidemia. Intervention: After >5 wks of persistent candidemia, caspofungin was added to an antifungal regimen that included amphotericin B and flucytosine. Measurements and Main Results: The addition of caspofungin resulted in rapid clearance of the candidemia. The child recovered without evidence of further fungal infection or overt toxicity. Conclusion: Caspofungin was administered safely in this pediatric patient and possibly contributed to her clinical improvement. Caspofungin may be considered in children with severe persistent fungal infections that are not responsive to standard therapy. More study in pediatric patients is necessary before recommending its general use.

Original languageEnglish (US)
Pages (from-to)181-183
Number of pages3
JournalPediatric Critical Care Medicine
Issue number2
StatePublished - 2004


  • Antifungal
  • Candidemia
  • Caspofungin
  • Child

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine


Dive into the research topics of 'Caspofungin in a pediatric patient with persistent candidemia'. Together they form a unique fingerprint.

Cite this